HHS Keeps 340B Orphan Drug Policy Despite Court Ruling

Law360, New York (June 18, 2014, 4:13 PM ET) -- The U.S. Department of Health and Human Services on Wednesday said a recent court decision will not prevent it from requiring orphan drugs to sometimes be discounted under the controversial 340B program and suggested drugmakers could be kicked out of Medicaid if they do not comply.



On the website of the Health Resources and Services Administration, which administers 340B, regulators said that while a judge vacated their orphan drug rule, that doesn’t invalidate their interpretation of federal law.



“HHS/HRSA continues to stand by the interpretation described...

To view the full article, register now.